These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12943451)

  • 1. Macrophages as novel cellular vehicles for gene therapy.
    Burke B
    Expert Opin Biol Ther; 2003 Sep; 3(6):919-24. PubMed ID: 12943451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets.
    Burke B; Sumner S; Maitland N; Lewis CE
    J Leukoc Biol; 2002 Sep; 72(3):417-28. PubMed ID: 12223508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting genetically modified macrophages to the glomerulus.
    Wilson HM; Kluth DC
    Nephron Exp Nephrol; 2003; 94(4):e113-8. PubMed ID: 12972709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A realistic chance for gene therapy in the near future.
    Worgall S
    Pediatr Nephrol; 2005 Feb; 20(2):118-24. PubMed ID: 15549408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals.
    Gervaix A; Schwarz L; Law P; Ho AD; Looney D; Lane T; Wong-Staal F
    Hum Gene Ther; 1997 Dec; 8(18):2229-38. PubMed ID: 9449376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy targeting kidney diseases: routes and vehicles.
    Isaka Y
    Clin Exp Nephrol; 2006 Dec; 10(4):229-35. PubMed ID: 17186326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy.
    Burke B; Giannoudis A; Corke KP; Gill D; Wells M; Ziegler-Heitbrock L; Lewis CE
    Am J Pathol; 2003 Oct; 163(4):1233-43. PubMed ID: 14507633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-focusing therapeutic gene delivery with intelligent gene vector swarms: intra-swarm signalling through receptor transgene expression in targeted cells.
    Tolmachov OE
    Artif Intell Med; 2015 Jan; 63(1):1-6. PubMed ID: 25547266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of HIV vectors for anti-HIV gene therapy.
    Poeschla E; Corbeau P; Wong-Staal F
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11395-9. PubMed ID: 8876146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of retroviral vectors for targeted delivery and expression of therapeutic genes.
    Salmons B; Saller RM; Baumann JG; Günzburg WH
    Leukemia; 1995 Oct; 9 Suppl 1():S53-60. PubMed ID: 7475314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches and methods in gene therapy for kidney disease.
    van der Wouden EA; Sandovici M; Henning RH; de Zeeuw D; Deelman LE
    J Pharmacol Toxicol Methods; 2004; 50(1):13-24. PubMed ID: 15233963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells.
    Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS
    Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma.
    Niess H; Bao Q; Conrad C; Zischek C; Notohamiprodjo M; Schwab F; Schwarz B; Huss R; Jauch KW; Nelson PJ; Bruns CJ
    Ann Surg; 2011 Nov; 254(5):767-74; discussion 774-5. PubMed ID: 22042469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of retroviral vectors for gene therapy.
    Salmons B; Günzburg WH
    Hum Gene Ther; 1993 Apr; 4(2):129-41. PubMed ID: 8494923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.
    Bai J; Rossi J; Akkina R
    AIDS Res Hum Retroviruses; 2001 Mar; 17(5):385-99. PubMed ID: 11282007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: dual gene expression in the context of HIV-2 LTR and Tat.
    Sadaie MR; Zamani M; Whang S; Sistron N; Arya SK
    J Med Virol; 1998 Feb; 54(2):118-28. PubMed ID: 9496370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress of gene recombinant mesenchymal stem cells as tumor targeting delivery vehicles].
    Zhang TY; Hu YL; Liang WQ; Gao JQ
    Yao Xue Xue Bao; 2013 Aug; 48(8):1209-20. PubMed ID: 24187826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus.
    Kluth DC; Erwig LP; Pearce WP; Rees AJ
    Gene Ther; 2000 Feb; 7(3):263-70. PubMed ID: 10694804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model.
    Blum JS; Barry MA; Mikos AG; Jansen JA
    Hum Gene Ther; 2003 Dec; 14(18):1689-701. PubMed ID: 14670121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.